Shalina Chatlani's profile photo

Shalina Chatlani

New York

Health Care Reporter at Stateline

health care reporter, investigator, bike + art girl. instagram: shalina.chatlani 📱3476510514 Tips: 📧 [email protected], signal: chatlanis.64

Featured in: Favicon nytimes.com Favicon npr.org Favicon apa.org Favicon usf.edu (+1) Favicon wbur.org Favicon marketplace.org Favicon marketingdive.com Favicon khn.org Favicon retaildive.com Favicon wgbh.org

Articles

  • 3 days ago | ncnewsline.com | Shalina Chatlani

    Even as Republicans in Congress walk back their most aggressive proposal to slash federal Medicaid spending, they are weighing other options that could force states to cut services for children and other vulnerable populations. U.S. House Speaker Mike Johnson told reporters last week that his caucus won’t reduce the 90% federal funding match that states get to cover working-age adults who became eligible for Medicaid under the Affordable Care Act.

  • 1 week ago | mercurynews.com | Shalina Chatlani

    By Shalina Chatlani, Stateline.orgThe Trump administration this month scrapped a Biden-era proposal that would have required state Medicaid programs and allowed federal Medicare to pay for some GLP-1s for obesity treatment. Instead, state Medicaid programs will retain the choice of whether to cover the high-priced medications for their residents.

  • 1 week ago | scdailygazette.com | Shalina Chatlani

    The Trump administration this month scrapped a Biden-era proposal that would have required state Medicaid programs and allowed federal Medicare to pay for some GLP-1s for obesity treatment. Instead, state Medicaid programs will retain the choice of whether to cover the high-priced medications for their residents. The drugs, which have historically been prescribed to diabetic patients, also help patients lose weight and have grown in popularity among doctors and patients.

  • 2 weeks ago | gazettextra.com | Shalina Chatlani

    The Trump administration this month scrapped a Biden-era proposal that would have required state Medicaid programs and allowed federal Medicare to pay for some GLP-1s for obesity treatment. Instead, state Medicaid programs will retain the choice of whether to cover the high-priced medications for their residents. The drugs, which have historically been prescribed to diabetic patients, also help patients lose weight and have grown in popularity among doctors and patients.

  • 2 weeks ago | thebrunswicknews.com | Shalina Chatlani

    The Trump administration this month scrapped a Biden-era proposal that would have required state Medicaid programs and allowed federal Medicare to pay for some GLP-1s for obesity treatment. Instead, state Medicaid programs will retain the choice of whether to cover the high-priced medications for their residents. The drugs, which have historically been prescribed to diabetic patients, also help patients lose weight and have grown in popularity among doctors and patients.

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

X (formerly Twitter)

Followers
2K
Tweets
5K
DMs Open
Yes
No Tweets found.